Suppr超能文献

筛查人群中导管癌、小叶癌和混合性导管小叶癌的危险因素。

Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.

机构信息

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

出版信息

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1643-54. doi: 10.1158/1055-9965.EPI-10-0188. Epub 2010 May 25.

Abstract

BACKGROUND

Biological distinctions between histologic subtypes of breast cancer suggest etiologic differences, although few studies have been powered to examine such differences. We compared associations between several factors and risk of ductal, lobular, and mixed ductal-lobular breast cancers.

METHODS

We used risk factor data from the Breast Cancer Surveillance Consortium for 3,331,744 mammograms on 1,211,238 women, including 19,119 women diagnosed with invasive breast cancer following mammography (n = 14,818 ductal, 1,602 lobular, and 1,601 mixed ductal-lobular). Histologic subtype-specific risk factor associations were evaluated using Cox regression.

RESULTS

Significant positive associations with family history and breast density were similar across subtypes. Hormone therapy use was associated with increased risk of all subtypes, but was most strongly associated with lobular cancer [hazard ratio (HR) = 1.46; 95% confidence interval (CI), 1.25-1.70]. Relative to nulliparous women, parous women had lower risk of ductal and mixed but not lobular cancers (HR = 0.80; 95% CI, 0.76-0.84; HR = 0.79; 95% CI, 0.68-0.93; HR = 0.96; 95% CI, 0.81-1.15, respectively). Late age at first birth was associated with increased risk of all subtypes.

CONCLUSIONS

Similarities in risk factor associations with ductal, lobular, and mixed breast cancer subtypes were more pronounced than differences. Distinctions between subtype-specific associations were limited to analyses of hormone therapy use and reproductive history.

IMPACT

The results of this study indicate that the strongest risk factors for breast cancer overall (that is, family history and breast density) are not histologic subtype specific. Additional studies are needed to better characterize subtype-specific associations with genetic, hormonal, and nonhormonal factors.

摘要

背景

乳腺癌组织学亚型之间存在生物学差异,提示存在病因学差异,但很少有研究有足够的能力来检验这些差异。我们比较了几种因素与导管癌、小叶癌和混合性导管小叶癌风险之间的关联。

方法

我们使用乳腺癌监测联盟的风险因素数据,对 1211238 名女性的 3331744 次乳房 X 光检查进行了分析,其中包括 19119 名经乳房 X 光检查诊断为浸润性乳腺癌的女性(n=14818 例导管癌、1602 例小叶癌和 1601 例混合性导管小叶癌)。采用 Cox 回归评估组织学亚型特异性风险因素的相关性。

结果

家族史和乳腺密度与各亚型均呈显著正相关。激素治疗与所有亚型的风险增加相关,但与小叶癌的相关性最强[风险比(HR)=1.46;95%置信区间(CI),1.25-1.70]。与未生育的女性相比,生育过的女性患导管癌和混合性乳腺癌的风险较低,但患小叶癌的风险较高(HR=0.80;95%CI,0.76-0.84;HR=0.79;95%CI,0.68-0.93;HR=0.96;95%CI,0.81-1.15)。首次生育年龄较晚与所有亚型的风险增加相关。

结论

导管癌、小叶癌和混合性乳腺癌亚型之间的风险因素相关性相似,差异不明显。亚型特异性关联的区别仅限于激素治疗使用和生殖史的分析。

影响

本研究结果表明,乳腺癌的最强危险因素(即家族史和乳腺密度)与组织学亚型无关。需要进一步研究以更好地描述与遗传、激素和非激素因素相关的亚型特异性关联。

相似文献

6
Menopausal hormone therapy and risk of clinical breast cancer subtypes.更年期激素治疗与临床乳腺癌亚型风险
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1188-96. doi: 10.1158/1055-9965.EPI-09-0002. Epub 2009 Mar 31.
8
Impact of hormone replacement therapy on the histologic subtype of breast cancer.激素替代疗法对乳腺癌组织学亚型的影响。
Arch Gynecol Obstet. 2008 Nov;278(5):443-9. doi: 10.1007/s00404-008-0613-8. Epub 2008 Mar 12.

引用本文的文献

1
Invasive lobular carcinoma with metastasis to the pectoralis muscle.浸润性小叶癌伴胸大肌转移。
Radiol Case Rep. 2025 Apr 5;20(6):3129-3133. doi: 10.1016/j.radcr.2025.03.051. eCollection 2025 Jun.

本文引用的文献

1
Menopausal hormone therapy and risk of clinical breast cancer subtypes.更年期激素治疗与临床乳腺癌亚型风险
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1188-96. doi: 10.1158/1055-9965.EPI-09-0002. Epub 2009 Mar 31.
6
Family history and breast cancer tumour characteristics in screened women.
Int J Cancer. 2008 Dec 15;123(12):2950-4. doi: 10.1002/ijc.23701.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验